Tag: equity
-
Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.
-
Migraine Drug Developer Raises $82.5M in IPO
A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock.
-
Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-
Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking
Stanford University, University of California in Berkeley, and Massachusetts Institute of Technology lead the undergraduate programs producing founders of start-up companies in 2019.
-
Sumitomo Dainippon, Biotechs in $3B Acquisition Deal
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group.
-
Gates Investing in HIV, Tuberculosis Immunotherapies
The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA.
-
Aging Therapy Network Adds $100M to Venture Round
An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round.
-
Infographic – A.I. Venture Deals Reach New Highs
The total amount of venture capital worldwide raised by artificial intelligence start-up companies set a record in the second quarter of 2019, reaching $7.4 billion.
-
Food Technology Company Gains $4M in Seed Funds
A company developing a food preservation technology from university materials science labs is raising $4 million in its seed funding round.
-
Infographic – U.S. Venture Funds Near 20-Year Highs
Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era.